TEMPORAL ALTERATIONS OF IMMUNOHISTOCHEMICAL FINDINGS IN POLYMYOSITIS

被引：13

作者：

TAJIMA, Y

MORIWAKA, F

TASHIRO, K

机构：

[1] Department of Neurology, Hokkaido University School of Medicine, Sapporo, 060, N15, W7, Kita-ku

[2] From the Department of Neurology, Hokkaido University School of Medicine, Sapporo

来源：

INTERNAL MEDICINE | 1994年 / 33卷 / 05期

关键词：

INFLAMMATORY MYOPATHY; IMMUNOHISTOCHEMISTRY; MHC-CLASS-I ANTIGEN; MHC-CLASS-II ANTIGEN; LYMPHOCYTE SUBPOPULATION;

D O I：

10.2169/internalmedicine.33.263

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

To investigate the pathological mechanisms of polymyositis, we performed immunohistochemical analyses with biopsied muscles. Comparative studies using specimens obtained from the same patient enabled us to analyze the pathological alterations at different sequential clinical phases without taking into account each immunogenetic difference. Expression of MHC (major histocompatibility complex) antigens, especially ectopic MHC-class-II antigens, in muscle fibers and infiltrating T-cells were shown to increase concomitantly with the clinically observed exacerbation. Moreover, other observations seem to support the possibilities that 1) administration of steroids lowers the number of invading CD8-positive cells, 2) induction of MHC-class-I antigens in muscle fibers precedes the inflammatory cell infiltration and that 3) remaining MHC-class-I antigens in muscle fibers may explain the recurrence of myositis often observed in the follow up period.

引用

页码：263 / 270

页数：8

共 12 条

[1]

Dalakas M., Polymyositis, dermatomyositis, and inclusion-body myositis, N Engl J Med, 325, 21, (1991)

[2]

Engel A.G., Arahata K., Mononuclear cells in myopathies. Quantification of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases, and implications for the pathogenesis of the different inflammatory myopathies, Hum Pathol, 17, 704, (1986)

[3]

Arahata K., Engel A.G., Monoclonal antibody analysis of mononuclear cells in myopathies. V: identification and quantification of T8+ cytotoxic and T8+ suppressor cells, 3, 23, (1988)

[4]

Behan W.H., Behan P.O., Durward W., Mcqueen A., The inflammatory process in polymyositis: monoclonal antibody analysis of muscle and peripheral blood immunoregulatory lymphocytes, J Neurol Neurosurg Psychiatry, 50, (1987)

[5]

Bohan A., Polymyositis and dermatomyositis, N Engl J Med, 291, (1975)

[6]

Plotz P.H., Dalakas M., Leff R.L., Cronin M.E., Current concepts in the idiopathic inflammatory myopathies: polymyositis, dermatomyositis and related disorders, Ann Intern Med, 111, 143, (1989)

[7]

Emile-Smith A.M., Arahata K., Engel A.G., Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies, Hum Pathol, 20, 224, (1989)

[8]

Young J.D., Cohn Z.A., Cell-mediated killing: a common mechanism?, Cell, 46, 641, (1986)

[9]

Zinkemagel R.M., Doherty P.C., MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function and responsiveness, Adv Immunol, 27, 51, (1979)

[10]

Martz E., Heagy W., Gromsowiski S.H., The mechanisms of CTL mediated killing: Monoclonal antibody analysis of the roles of killer and target-cell membrane proteins, Immunol Rev, 72, 73, (1983)

← 1 2 →